Search the Newsreel

Is AXIS Capital Holdings (AXS) Undervalued On Its Earnings Miss?

AXIS Capital Holdings (AXS) recently reported an earnings miss, with revenue and EPS below Wall Street forecasts, leading to an 11.16% share price drop. Despite this, the company has shown strong long-term momentum, with 1-year and 5-year total shareholder returns of 15.07% and 136.75% …

AXIS Capital adds Rahil Jogani to newly created role as Head of Technology & AI Strategy

AXIS Capital Holdings Limited has appointed Rahil Jogani as Head of Technology & AI Strategy, a newly created role based in New York. Jogani, formerly a Partner at McKinsey & Company, will be responsible for defining and advancing the re/insurer's enterprise technology and AI …

Why AXIS Capital (AXS) Stock Is Nosediving

Why AXIS Capital (AXS) Stock Is Nosediving What Happened? Shares of global specialty insurer AXIS Capital Holdings Limited (NYSE:AXS) fell 11.6% in the afternoon session after the company reported second-quarter results that missed Wall Street's expectations for both revenue and earnings. The company posted …

AXIS Capital Holdings Number of Employees 2026 | Employee Count & Headcount Data

This article provides an in-depth analysis of AXIS Capital Holdings's employee count and workforce trends as of March 2026, based on Revelio Labs data. It details a slight decline in total headcount since 2023 but notes current active hiring. Key insights include geographic distribution …

Axis Capital Holdings Limited $AXS Shares Acquired by Sei Investments Co.

Sei Investments Co. increased its stake in Axis Capital Holdings Limited (NYSE:AXS) by 10.6% during the first quarter, now holding 224,164 shares valued at $22.7 million. Despite reporting a 16% year-over-year increase in second-quarter net income to $251 million and profitable underwriting, the company's …

AXIS Capital slides after Q2 results show weaker underwriting and an earnings miss

AXIS Capital (AXS) saw its stock price decline by 11.2% following its Q2 2026 earnings release, which revealed weaker underwriting results and an earnings miss. Despite an increase in net income, investors focused on the operating EPS miss, a higher combined ratio, and larger …

AXIS Appoints Rahil Jogani as Head of Technology & Artificial Intelligence Strategy

AXIS Specialty US Services Inc. PEMBROKE, Bermuda, July 29, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited ("AXIS Capital," "AXIS" or the "Company") (NYSE: AXS) today announced that it has hired Rahil Jogani to the newly created role of Head of Technology & Artificial …

Former McKinsey partner joins AXIS to lead AI strategy after 16 years

AXIS Capital (NYSE: AXS) has appointed Rahil Jogani, a former McKinsey & Company partner, as its new Head of Technology & Artificial Intelligence Strategy. In this role, Jogani will drive the company's enterprise technology and AI agenda, focusing on integrating AI and emerging technologies …

Earnings call transcript: AXIS Capital Q2 2026 earnings miss weighs on shares

AXIS Capital Holdings reported Q2 2026 operating earnings of $2.84 a share, missing Wall Street forecasts, although revenue beat expectations. The mixed results led to a nearly 9.5% drop in shares, as investors focused on the earnings shortfall and signs of softening pricing in …

SummitTX Capital L.P. Makes New $2.59 Million Investment in Axsome Therapeutics, Inc. $AXSM

SummitTX Capital L.P. has made a new $2.59 million investment in Axsome Therapeutics, Inc. by purchasing 15,304 shares. This move is part of the broader institutional interest in Axsome Therapeutics, with other hedge funds also adjusting their positions. Despite a wider-than-expected quarterly loss, analysts …

AXIS Capital’s net income rises to $251m for Q2’26

AXIS Capital Holdings Limited reported a 16% increase in net income for Q2 2026, reaching $251 million, and a 24% rise to $498 million for H1 2026. Despite a dip in group-wide underwriting income and a higher combined ratio, gross written premiums increased, primarily …

AXIS Capital Holdings Ltd Q2 2026: Revenue $1.519B, EPS $3.38— 10-Q Summary

AXIS Capital Holdings Ltd (AXS) reported strong second-quarter 2026 results, with revenue reaching $1.519 billion, a 9% increase year-over-year, and diluted EPS of $3.38, up 24% from the prior year. Net income available to common shareholders also rose significantly to $250.5 million. The company's …

Earnings Flash (AXS) AXIS Capital Holdings Limited Reports Q2 Revenue $1.75B, Vs. FactSet Est of $1.74B

AXIS Capital Holdings Limited (AXS) announced its Q2 financial results, reporting revenue of $1.75 billion. This figure slightly exceeded FactSet's estimated revenue of $1.74 billion, indicating a positive performance for the quarter.

AXIS Capital Q2 Earnings Miss Estimates on Higher Catastrophe Losses

Cat losses push AXIS Capital combined ratio to 93.1% in Q2 2026

AXIS Capital Holdings Limited reported a 16% year-on-year increase in net income for Q2 2026, despite its consolidated combined ratio rising to 93.1% due to elevated catastrophe losses totaling US$80 million. Underwriting income fell by 24% as natural catastrophes and the Middle East conflict …

Axsome Therapeutics Inc (AXSM) Valuation: PE, PB & Fair Value Analysis

This article analyzes the valuation of Axsome Therapeutics Inc (AXSM), noting its current valuation score of 9.71, ranking 10th in the Pharmaceuticals industry. The P/E ratio is reported at -62.84, which is significantly below its recent high and slightly above its recent low. The …

Here's What Key Metrics Tell Us About Axis Capital (AXS) Q2 Earnings

Axis Capital (AXS) reported $1.71 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 7.4%. EPS of $2.84 for the same period compares to $3.29 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $1.72 …

AXIS CAPITAL HOLDINGS LTD SEC Filing (Jul 28, 2026)

AXIS Capital Holdings Limited (AXS) filed an IRANNOTICE SEC filing on July 28, 2026. This notice confirms that the company made a disclosure in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, as required by Section 219 of the …

Axis Capital earnings missed by $0.44, revenue topped estimates

Axis Capital (NYSE: AXS) reported Q2 EPS of $2.84, missing analyst estimates by $0.44, although revenue of $1.75 billion topped the consensus estimate of $1.74 billion. The company's stock price has risen 19.10% over the last three months and 22.77% over the last 12 …

Axis Capital: Q2 Earnings Snapshot

AXIS Capital Reports Second Quarter Net Income Available to Common Shareholders of $251 Million, or $3.38 Per Diluted Common Share and Operating Income of $211 Million, or $2.84 Per Diluted Common Share

AXIS Specialty US Services Inc. For the second quarter of 2026, the Company reports: Annualized return on average common equity ("ROACE") of 17.0% and annualized operating ROACE of 14.3% Combined ratio of 93.1%, producing underwriting income of $143 million Book value per diluted common …

Axis Capital earnings up next: Profitability test as rates soften By Investing.com

AXIS Capital Holdings Ltd. is preparing to report its second-quarter earnings, with analysts expecting diluted EPS of $3.24 and revenue of $1.74 billion. Investors will closely watch how the specialty insurer navigates softening property catastrophe reinsurance rates and maintains profitability amid increased market competition …

Healthcare of Ontario Pension Plan Trust Fund Invests $16.49 Million in Axsome Therapeutics, Inc. $AXSM

The Healthcare of Ontario Pension Plan Trust Fund has invested $16.49 million in Axsome Therapeutics, acquiring 97,550 shares. This comes as institutional investors now own 81.49% of the company, despite recent insider sales totaling $37.23 million. Axsome Therapeutics reported significant revenue growth of 57.4% …

Axis Capital (NYSE:AXS) Releases Quarterly Earnings Results, Misses Estimates By $0.41 EPS

Axis Capital (AXS) came out with quarterly earnings of $2.84 per share, missing the Zacks Consensus Estimate of $3.23 per share. This compares to earnings of $3.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

AXIS Capital (NYSE: AXS) posts 91.5% H1 2026 combined ratio

Axis Capital (AXS) Misses Q2 Earnings and Revenue Estimates

AXIS Capital (NYSE:AXS) Reports Adjusted EPS Below Analyst Estimates In Q2 CY2026 Earnings

AXIS Capital (NYSE:AXS) Reports Adjusted EPS Below Analyst Estimates In Q2 CY2026 Earnings Global specialty insurer AXIS Capital Holdings Limited (NYSE:AXS) missed Wall Street's revenue expectations in Q2 CY2026, but sales rose 10.3% year on year to $1.75 billion. Its non-GAAP profit of $2.84 …

AXIS Capital writes $2.7B in premiums; insurance rises 15%

Is AXIS Capital Holdings (AXS) A Bargain As Earnings Approach?

AXIS Capital Holdings (AXS) is poised to release its quarterly earnings, with market expectations of 11.3% year-on-year revenue growth. Despite strong recent share price performance, the stock is considered undervalued with a fair value of $126.09, according to Simply Wall St. The company's strategic …

BlackRock, Inc. (AXSM) reports 2.74M Axsome Therapeutics shares in Schedule 13G/A

BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a beneficial ownership of 2,736,503 shares of Axsome Therapeutics, Inc. common stock, which represents a 5.3% stake. BlackRock maintains sole voting power over 2,649,256 shares and sole dispositive power over all …

What AXIS Capital Holdings (AXS)'s Anticipated Revenue Reacceleration And Earnings Release Means For Shareholders

AXIS Capital Holdings (AXS) is set to release its quarterly earnings, with analysts anticipating an 11.3% year-on-year revenue increase, a significant jump from previous quarters. This report will be crucial in determining if underwriting profitability is keeping pace with the revenue growth, especially given …

Axsome Therapeutics, Inc. $AXSM Shares Sold by Orbimed Advisors LLC

Orbimed Advisors LLC reduced its stake in Axsome Therapeutics ($AXSM) by 15.5% in the first quarter, selling 39,200 shares and retaining 213,921 shares valued at $36.2 million. Despite the company reporting Q1 revenue of $191.2 million, which beat estimates, it posted an adjusted loss …

Axsome Therapeutics Inc (AXSM) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides information on Axsome Therapeutics Inc (AXSM) regarding its dividend history and stock splits. It indicates that the company has distributed a total of $0.00 in dividends over the past five years, with "No Data" available for specific dividend dates. The page …

AXIS Capital (AXS) To Report Earnings Tomorrow: Here Is What To Expect

AXIS Capital (AXS) To Report Earnings Tomorrow: Here Is What To Expect Global specialty insurer AXIS Capital Holdings Limited (NYSE:AXS) will be reporting results this Tuesday after market hours. Here's what investors should know. AXIS Capital missed analysts' revenue expectations last quarter, reporting revenues …

Caxton Associates LLP Makes New Investment in Axsome Therapeutics, Inc. $AXSM

Caxton Associates LLP has made a new investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) by purchasing 4,311 shares worth approximately $729,000 during the first quarter. Institutional investors now own 81.49% of the company, and analysts have a "Moderate Buy" rating with an average price target …

AXS|AXIS Capital Holdings Ltd|Price:116.500|Chg%:+1.920

This article provides a detailed financial overview of AXIS Capital Holdings Ltd (AXS), including its stock performance, market capitalization, P/E ratio, and upcoming earnings date. It presents comprehensive financial statements like the income statement, balance sheet, and cash flow statement, along with key financial …